✦ LIBER ✦

Phase II Pilot Study of Intravenous High-Dose Interferon With or Without Maintenance Treatment in Melanoma at High Risk of Recurrence

✍ Scribed by Payne, M. J.; Argyropoulou, K.; Lorigan, P.; McAleer, J. J.; Farrugia, D.; Davidson, N.; Kelly, C.; Chao, D.; Marshall, E.; Han, C.; Wellman, S.; Middleton, M. R.

Book ID: 127370357
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 138 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2013.49.8717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of dacarbazine, cisplat

A phase II study of dacarbazine, cisplatin, interferon-α and high-dose interleukin-2 in ‘poor-risk’ metastatic melanoma

✍ T.M. Proebstle; C. Scheibenbogen; W. Sterry; U. Keilholz 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 452 KB

Phase II study of second-line treatment

Phase II study of second-line treatment with high-dose cyclophosphamide in recurrent metastatic breast cancer

✍ Flemming Hansen; Peter Møller; Torben Skovsgaard 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 216 KB

Phase I/II study of treatment with matur

Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma

✍ P. Hersey; G. M. Halliday; M. L. Farrelly; C. DeSilva; M. Lett; S. W. Menzies 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 577 KB

Final results of a phase I/II pilot stud

Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer

✍ Volkmar Müller; Christoph Thomssen; Marcus Schmidt; Manfred Glados; Christian Ja 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 300 KB

78 A RANDOMIZED PILOT PHASE II STUDY OF

78 A RANDOMIZED PILOT PHASE II STUDY OF THALIDOMIDE AS ADJUVANT THERAPY IN PATIENT WITH HIGH RECURRENCE RISK HEPATOCELLULAR CARCINOMA

✍ M.-C. Ho; R.-H. Hu; C.-M. Ho; C.-N. Chen; K.-J. Chang; P.-H. Lee 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase II trial of high-dose intravenous

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

✍ Morgan, R J; Doroshow, J H; Leong, L; Schriber, J; Shibata, S; Forman, S; Hamasa 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB